Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05807620 · ClinicalTrials.gov registry record · NA

A 12 Week Study to Evaluate the Efficacy of an Eye Cream

A NA study of Wrinkle and Fine Lines, sponsored by Revision Skincare.

Completed
Registry status
NA
Development phase
40
Enrollment target
1
Study location

NCT05807620 is a NA study of Wrinkle and Fine Lines that has completed, run by Revision Skincare. The registered enrollment target is 40 participants, below the 119-participant average among 25 other Wrinkle trials with a reported enrollment target (66% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05807620, a NA study of Wrinkle and Fine Lines, has completed, sponsored by Revision Skincare.

COMPLETED
Registry status
NA
Development phase
40 participants
Enrollment target
1
Study location

Study Summary

This single center, open-label clinical study was conducted to assess the efficacy and tolerance of a topical eye cream when used over the course of 12 weeks by healthy women with moderate to severe under-eye dark circles, moderate under eye puffiness, and mild fine lines and wrinkles. A total of 37 subjects were enrolled into the study.

Interventions

  • OTHER Facial Moisturizer
  • OTHER Gentle Cleansing Lotion
  • OTHER Sunscreen SPF 30

Study Locations (1)

New Jersey

  • Validated Claim Support, LLC - Teaneck

Trial Details

FieldValue
Enrollment Target 40 participants
Start Date 2022-01-01
Est. Completion 2022-07-01
Phase NA

Sponsor

Revision Skincare

18 total trials

What the Registry Record Tells You About NCT05807620

The ClinicalTrials.gov registry entry for NCT05807620 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 40 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 119-participant average among 25 other Wrinkle trials with a reported enrollment target (66% lower). The listed sponsor is Revision Skincare, which has 18 total studies on file at ClinicalTrials.gov.

The record links to 4 conditions, with Wrinkle appearing as the primary indexed condition, and to 3 interventions - of which Facial Moisturizer is the first listed.

NCT05807620 reports 1 study location spanning 1 distinct geographic area - top geographies include New Jersey.

Frequently Asked Questions

What is clinical trial NCT05807620 about?

NCT05807620 is a clinical study titled "A 12 Week Study to Evaluate the Efficacy of an Eye Cream". This single center, open-label clinical study was conducted to assess the efficacy and tolerance of a topical eye cream when used over the course of 12 weeks by healthy women with moderate to severe under-eye dark circles, moderate under eye puffiness, and mild fine lines and wrinkles. A total of 37...

What is the current status of trial NCT05807620?

This trial is currently completed. It is a NA study. The enrollment target is 40 participants. The study started on 2022-01-01. Estimated completion is 2022-07-01.

What conditions does trial NCT05807620 study?

This clinical trial studies the following conditions: Wrinkle, Fine Lines, Periorbital Edema, Periorbital Hyperpigmentation.

What interventions are being tested in trial NCT05807620?

The interventions under investigation include: Facial Moisturizer (OTHER), Gentle Cleansing Lotion (OTHER), Sunscreen SPF 30 (OTHER).

Who is sponsoring clinical trial NCT05807620?

This trial is sponsored by Revision Skincare, which has 18 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05807620 being conducted?

This trial has 1 study location across New Jersey. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Wrinkle

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.